With a passion for drug design, and enabled by an innovative chemistry platform, Akanocure is a drug development company with a focus on orphan and unmet needs in oncology. We are applying our expertise throughout the drug discovery and development process to create novel small molecules that will positively impact the lives of cancer patients. It is our mission to find therapeutic approaches that block metastatic processes. Metastasis is responsible for 90% of cancer deaths. Medical efforts usually fail in managing the disease once it spreads through the body. We created a tight integration between the development of chemical methodologies and classic drug discovery expertise. Our company culture is shaped by the collaboration and partnership between our team of experts and industry leaders, academia, and government. Together, we are developing drugs that will make a difference in patients’ lives.
Something looks off?